Vula Mobile’s Post

👩⚕️ A Round of Applause for Our Family Doctors 👨⚕️ Family doctors, you are the unsung heroes of healthcare, often called upon to be experts in everything. With hundreds of patients and a wide range of symptoms crossing your desk, your role is essential in guiding patients toward the best care possible. When it comes to Urticaria, you’re often the first point of contact. You help patients manage their symptoms by prescribing antihistamines to provide immediate relief. But we know you want more for your patients than just short-term comfort—you want a long-term solution that truly works. By referring patients with persistent hives to LEADER Research, you’re contributing to groundbreaking studies that aim to find lasting treatments for Urticaria. Your expertise starts the journey, and by connecting your patients with specialized care, you’re helping advance science and find a cure that benefits everyone. Together, we can provide the best care today while shaping the future of dermatology tomorrow. 👉 Refer your patients with chronic Urticaria to LEADER Research, and let’s work together to find a solution that works for the long term. — #ClinicalTrials #UrticariaResearch #MedicalResearch #ScientificAdvancement #DermatologyResearch #ChronicHives #ResearchMatters #ClinicalStudy #ImmunologyResearch #PatientCareInnovation #SkinHealthStudies #HealthResearch #ClinicalInnovation #HealthcareAdvancement #ClinicalTrialAwareness #MedicalBreakthroughs #ScientificDiscoveries #HealthScience #InnovativeHealthcare #ChronicIllnessResearch #UrticariaAwareness #MedicalTrials #ResearchForACure #TrialParticipantsNeeded #ClinicalProgress #HealthScienceResearch #DermatologyAdvances

🚀 #Uro-#Gynaecological #Surgical #Devices #Market is Booming! 🚀 Get Info : https://shorturl.at/WFgiM The Uro-Gynaecological Surgical Devices market is projected to grow at a CAGR of 9.3% from 2023 to 2029, reaching a market value of $7.80 Bn by 2029. Market Overview: Urogynecology, a #subspecialty of #obstetrics and gynecology, focuses on female pelvic floor disorders like pelvic organ prolapse (POP) and stress urinary incontinence (SUI), affecting 30-40% of #women #globally. Market Drivers: Increasing acceptance of minimally invasive #surgical #procedures Rising prevalence of urological disorders among women Rapidly increasing geriatric population Challenges: High cost of treatment Lack of skilled professionals Poor healthcare systems in underdeveloped regions Key Segments: By Procedure: Dilation and Curettage, Uterine Balloon Therapy, Hysteroscopy, Tubal Ligation, Myomectomy By Disease: Pelvic Organ Prolapse, Urinary Incontinence, Others Key Players: Stryker Corporation Boston Scientific Corporation Medtronic Inc. Ethicon Inc. Gyrus ACMI Cook Urological Inc. #UroGynecology #MedicalDevices #HealthcareInnovation #MarketGrowth

Urological procedures are not without their challenges—risks like infections and complications can arise from even minor oversights. At AJ Medichem, we understand that every detail matters. Our state-of-the-art urology solutions are designed to empower healthcare professionals to proactively manage these risks and provide safe, effective care. Don’t leave patient safety to chance; elevate your practice with trusted solutions that prioritize well-being. #UrologyAwareness #HealthcareRisks #AJMedichem #PatientSafety #InnovativeSolutions

We are pleased to share our latest report on the #PhysicianPractice Management market landscape. The U.S. physician practice market was valued at $324.8 billion in 2023 and is expected to grow at a CAGR of 5.1%, reaching $438.1 billion by 2028. As the U.S. population continues to grow and age, the demand for physician services is continually rising. From now until 2029, it is anticipated that there will be a 42.4% increase in individuals aged over 65, showcasing the need for medical services across specialties. As it stands today, single-specialty practices represent 60.5% of the entire market, and sectors such as gynecology, dermatology, ophthalmology, and urology are the most targeted single-specialty practices when it comes to consolidation. This said, due to the ability for #MultiSpecialty practices to control the patient journey and care for conditions of varying modalities, this segment is anticipated to grow faster than its single-specialty counterpart, increasing M&A activity in the multi-specialty orthopedics and primary/urgent care markets. With forecasted physician shortages across specialties on the horizon, many stand-alone practices are seeking to partner with strategic and financial buyers alike to assist in streamlining operations and bolstering physician recruitment, ultimately aiding in practice expansion to help cover potential care gaps in the future. Hyde Park Capital's healthcare coverage team is one of the most active physician practice investment banking groups nationally, covering many specialties including Cardiology, Orthopedics, Gastroenterology, Dermatology, Primary Care, Dentistry, OBGYN, Pain Management, Cosmetic, and Ambulatory Surgery Centers more broadly. Please reach out to Josh Mastracci, Joshua Paul, or another member of our healthcare coverage team with any questions you might have about this report. We’d be happy to discuss what we’re seeing in the market and how that could relate to your company or clients. Download Full Report -> https://lnkd.in/g86fqjw4 #investmentbanking #businessowner #mergersacquisitionsdivestitures #privateequity #healthcare #ambulatorysurgerycenter

Dr. Tomecki was brought into the room by another physician.  I have been diagnosed with Follicular Mucinosis by American Dermatopathology Laboratory. Case Number D23-6809, Follicular Mucinosis (L65.8) Gross Description : they received in formalin a 5x5x9 mm cutaneous cylindrical specimen, bisected and submitted entirely in one cassette. sf/cm. Report: Microscopic Examination: This is a cutaneous punch biopsy showing intrafollicular spongiosis and a perifollicular lymphocytic in filtration. In addition, there is a perivascular superficial and deep lymphocytic infiltrate with eosinophils.  Colloidal iron stain demonstrated the presence of intrafollicular mucin, and such finding is supportive of the diagnosis. PAS stain is negative for fungal element. My Cincinnati Area Doctor thought i should see someone at the Cleveland Clinic because it is a rare autoimmune. So, I am undressed, he comes in, looks at my back, chest and feet. He declares I have Eczema; I said the dermatopathology reports i have FM, he said no, you don't you are blond, light skinned and have Eczema. I reply, I have the report, i reach for it from my husband, I try to hand to him, he moves my hand, I said, so you say i have eczema, but I have a pathology report that differs. He opens the door, I look at the other doctor, and say, "how could all of the records i have and including a path report be wrong?" He swings open the door, it bangs on the wall stopper, and stands in front of me and states he has been doing this for 30 years and he knows, I again try to hand him the report, he then pushes my hand away and storms out shutting the door loudly. I look again a the other doctor, she says put this cream on my skin, which by the way, I have been doing since the onset of FM, and says she wants to refer me to a Rheumatologist. So, if you want a doctor who can look at you visually and know what problem you have, without blood, pathology and other doctor reports then, "this is the guy for you!"  I might add that they had no reports prior to me arriving for review, nor did Dr. Tomecki ever have the chance to review docs prior.  It was my very 1st visit and I was referred by my Dermatologist and MD. The records were not on the system, as the nurse that came in 1st told her it was all on my charts. The whole visit was less than 5 minutes in total.  On the way home I called the American Dermatopathology Lab, they put the pathologist on, he pulled the case number and reiterated the same, that yes, the report was correct, and he supports his findings. I was treated with the worst display of conduct from a professional, all the way down to throwing his arms up in the air, raising his voice and a multitude of infractions of conduct less than that of a Physician.  

🩸 𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐇𝐞𝐦𝐨𝐬𝐭𝐚𝐬𝐢𝐬: 𝐓𝐡𝐞 𝐑𝐨𝐥𝐞 𝐨𝐟 𝐏𝐨𝐥𝐲𝐬𝐚𝐜𝐜𝐡𝐚𝐫𝐢𝐝𝐞 𝐇𝐞𝐦𝐨𝐬𝐭𝐚𝐭𝐢𝐜 𝐏𝐨𝐰𝐝𝐞𝐫 𝐢𝐧 𝐌𝐨𝐝𝐞𝐫𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 💡 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gJSPgjmu The medical polysaccharide hemostatic powder market is growing steadily, driven by the increasing demand for advanced hemostatic solutions in surgical and emergency care settings. Polysaccharide hemostatic powders are derived from natural starch-based materials that accelerate the body’s natural clotting process. These powders are used to control bleeding effectively in various surgical procedures, trauma cases, and emergency settings, offering a quick and efficient way to manage hemostasis. The rising need for safer, faster, and more effective bleeding control solutions is contributing to the market’s expansion, especially with the growing emphasis on minimally invasive surgeries and advanced wound care. One of the primary drivers of the medical polysaccharide hemostatic powder market is the increasing number of surgeries worldwide. As surgical procedures, particularly in fields like cardiovascular surgery, trauma care, and orthopedics, continue to rise, the demand for reliable and efficient hemostatic agents that can rapidly stop bleeding and promote healing is growing. Additionally, the aging global population, which is more susceptible to conditions requiring surgical intervention, further drives the demand for hemostatic powders in healthcare facilities. These powders are preferred due to their biocompatibility, ease of use, and effectiveness in controlling bleeding in various clinical situations. #Company ENDOCLOT PLUS, INC. Baxter International Inc. Hemostasis, LLC Singclean Medical Products Johnson & Johnson BD Zhonghui Shengxi Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Saikesaisi Holdings Group Boz Medical #Type Polysaccharide Hemostatic Powder Absorbable Modified Polymer #Application Hospital Clinic Other #MedicalInnovation #HemostaticPowder #HealthcareTechnology #TraumaCare #SurgicalSolutions #Polysaccharide #MedicalDevices #HealthcareMarket

Non-invasive treatment for residual lesions of involuted infantile hemangiomas Georgetown University researchers developed a potential non-surgical approach for infantile hemangioma lesions using bile acid or its salt, offering affordability and safety benefits over current treatments. 🏥 How it works: 🚫 Non-invasive: Non-surgical treatment utilizing bile acid-based drug for infantile hemangioma lesions. 💊 Administration-Utilizing bile acid or its salt offers potential cost savings for patients. 🛡️ Safety- Promises enhanced safety profile compared to existing treatment methods. Benefits: 🩹 Minimized Risk: Minimizes risks associated with surgery and anesthesia 💰 Cost effective: Expected cost-effectiveness and reduced invasiveness compared to current methods Join us in Revolutionizing Non-Invasive Solutions for Infantile Hemangioma Lesions Care. Cynthia DeKlotz     Michael Andrew Cardis #noninvasive treatment #infantile hemangioma #innovation #GeorgetownOTC #georgetownuniversity Link to More Information: [https://lnkd.in/eWkyCvbY]

How do you stay updated with the latest research findings in ophthalmology? Follow DJCRO on Instagram, X, and LinkedIn - stay in the know! 👀 Check out our latest case reports here: https://lnkd.in/eMKUiD6R Have a fun and safe holiday! #ophthalmology #medicine #research

Are you really capable of outfitting your clinic with the best urology tables? It's easy to second-guess your choices when it comes to crucial medical equipment. Everyone's been there, questioning if they’re making the right moves, especially when patient care is on the line. But here’s the thing, you shouldn’t let doubt stop you from reaching your goal, especially in healthcare. At Global Star Medical, we understand these challenges. We distribute Durabuilt Medical urology tables that blend quality, affordability, and accessibility. These aren't just any tables; they are the foundation for better patient outcomes in urology centers. We are committed to ensuring healthcare facilities like yours have the support and equipment you need. Don't hesitate to reach out to us for insights and options that cater to both your budget and your patients' needs. Hit up our website and let's talk about elevating patient care together. #UrologyCare #MedicalEquipment #GlobalStarMedical

Optimize Your Urology Practice with Specialized Billing Services Urology practices require precise and efficient billing to ensure accurate reimbursements and smooth revenue cycles. At A Medi Solution, our Urology Medical Billing Services are tailored to meet the unique needs of urology providers, helping you enhance financial performance and focus on patient care. Why Our Urology Billing Services? Specialized Expertise: We understand the complexities of urology billing, ensuring accurate coding and timely claim submissions. Maximized Revenue: Our proactive approach reduces denials and optimizes reimbursement, ensuring your practice receives the revenue it deserves. Compliance & Accuracy: Stay compliant with the latest regulations while minimizing billing errors and avoiding costly mistakes. Comprehensive Reporting: Detailed financial reports provide valuable insights, helping you make informed decisions for your practice. Patient-Centered Focus: Let us manage billing inquiries and administrative tasks, allowing you to dedicate more time to your patients. Streamline your billing process and improve your practice’s financial health with A Medi Solution. Trust our expertise to handle the complexities while you concentrate on delivering exceptional urological care. Contact us to learn more: Email: info@amedisolution.com Call # (888)508-6818 #UrologyBilling #MedicalBilling #RevenueCycleManagement #HealthcareFinance #AMediSolution #MedicalBillingCompany #HealthCare